Differential expression analysis (DEA) was firstly performed within diagnostic groups between APOE4 carriers (2/4, 3/4 and 4/4) and non-carriers (e.g., APOE4 carriers with AD pathology vs. non-carriers with AD pathology) in the ROSMAP-PFC dataset. The gene discussed is APOE; the disease is Alzheimer disease.